Merck KGaA (0O14.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:33PM BST
| Previous close | 154.75 |
| Open | 155.10 |
| Bid | 157.25 x 0 |
| Ask | 161.60 x 0 |
| Day's range | 148.35 - 159.95 |
| 52-week range | 20.40 - 184.08 |
| Volume | |
| Avg. volume | 95,295 |
| Market cap | 73.906B |
| Beta (5Y monthly) | 0.65 |
| PE ratio (TTM) | 22.57 |
| EPS (TTM) | 7.08 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | 2.20 (1.48%) |
| Ex-dividend date | 02 May 2023 |
| 1y target est | N/A |
PR NewswireASNA and Athinia® collaborate to boost semiconductor manufacturing yields through improved data sharing and traceability of subcomponent parts
Today Athinia® announced a collaboration with ASNA to combine unprecedented data sharing and traceability to improve critical semiconductor component and subcomponent innovation. In today's fiercely competitive semiconductor landscape, the quality and reliability of components and subcomponents are paramount for achieving superior yield rates and minimizing defects during manufacturing.
- Investing.com
Merck KGgA shares slide after failure of potential head and neck cancer drug
Investing.com -- Shares in Merck KGaA (ETR:MRCG) slumped by more than 10% on Tuesday after the drugmaker announced that it had discontinued a Phase III study evaluating its treatment for patients with head and neck cancer.
Simply Wall St.Merck KGaA's (ETR:MRK) Stock Has Fared Decently: Is the Market Following Strong Financials?
Most readers would already know that Merck KGaA's (ETR:MRK) stock increased by 4.5% over the past three months. Given...
© 2024 Yahoo. All rights reserved.